The PD-L1 Promoter Methylation Predicts Gene And Protein Expression Levels in Urothelial Carcinoma
Gene · 2025
DOI: 10.1016/j.gene.2025.149503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene, 2025. Verfasst von Cansu Barış Moğul und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, School of Medicine, Pamukkale University, Denizli, Turkey. Electronic address: ibaris@pau.edu.tr. Hauptthemen laut MEDLINE: DNA Methylation, B7-H1 Antigen, Promoter Regions, Genetic, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Pamukkale Üniversitesi.
Abstract (Originalsprache)
We aimed to clarify the role of PD-L1 promoter methylation in bladder cancer by analyzing PD-L1 methylation and mRNA expression in FFPE samples, along with PD-L1 mRNA and protein levels in urine samples from bladder urothelial carcinoma patients. We analyzed PD-L1 promoter methylation in 43 bladder urothelial carcinoma tissue samples and 41 non-malignant bladder tissues using methylation-sensitive high-resolution melting analysis to assess two CpG islands (cg15837913, cg19724470). PD-L1 mRNA expression in tissues and urine samples, along with PD-L1 protein levels in urine, were evaluated. The bladder urothelial carcinoma group showed significantly higher methylation rates for cg19724470 and cg15837913 compared to controls (P = 0.016, P = 0.049 respectively). In the patient group, tissue PD-L1 mRNA expression was 15.22 times higher and urinary PD-L1 mRNA expression 6.56 times higher in the cg19724470 unmethylated group compared to the methylated group. Urinary PD-L1 protein concentration was twice as high in the cg19724470 unmethylated group compared to the methylated group. In the patients, tissue PD-L1 mRNA expression was 4.58 times higher and urinary PD-L1 mRNA expression 2.58 times higher in the cg15837913 unmethylated group compared to the methylated group. Moreover, the urinary PD-L1 protein concentration was 1.7 times higher in the cg15837913 unmethylated group than in the methylated group (P = 0.036). A positive correlation was observed between tissue PD-L1 mRNA and both urine PD-L1 mRNA and protein levels and between urine PD-L1 mRNA and protein levels. This study suggests that PD-L1 methylation may be a key epigenetic regulator influencing PD-L1 expression and disease pathogenesis in bladder urothelial carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, School of Medicine, Pamukkale University, Denizli, Turkey. Electronic address: ibaris@pau.edu.tr.
- Department of Urology, School of Medicine, Pamukkale University, Denizli, Turkey. Electronic address: mbduran@pau.edu.tr.
- Department of Medical Genetics, School of Medicine, Pamukkale University, Denizli, Turkey; Sapiens Genetics Diagnostic Center, İstanbul, Turkey. Electronic address: vcaner@pau.edu.tr.
- Department of Medical Pathology, School of Medicine, Pamukkale University, Denizli, Turkey. Electronic address: sennilay@pau.edu.tr.
- Department of Urology, School of Medicine, Pamukkale University, Denizli, Turkey.
Förderung
- Pamukkale Üniversitesi
Zitieren
APA
Barış Moğul, C., Duran, M. B., Caner, V., Türk, N. Ş., & Tuncay, Ö. L. (2025). The PD-L1 Promoter Methylation Predicts Gene And Protein Expression Levels in Urothelial Carcinoma. Gene. https://doi.org/10.1016/j.gene.2025.149503
Vancouver
Barış Moğul C, Duran MB, Caner V, Türk NŞ, Tuncay ÖL. The PD-L1 Promoter Methylation Predicts Gene And Protein Expression Levels in Urothelial Carcinoma. Gene. 2025. doi:10.1016/j.gene.2025.149503
BibTeX
@article{BarMoul2025,
author = {Barış Moğul, Cansu and Duran, Mesut Berkan and Caner, Vildan and Türk, Nilay Şen and Tuncay, Ömer Levent},
title = {The PD-L1 Promoter Methylation Predicts Gene And Protein Expression Levels in Urothelial Carcinoma},
journal = {Gene},
year = {2025},
doi = {10.1016/j.gene.2025.149503}
}
EUVIMED